Skip to main content
SpringerLink
Log in

Haematological Adverse Effects of Histamine H2-Receptor Antagonists

  • Review Article
  • Adverse Drug Experience Review
  • Published:
Medical Toxicology and Adverse Drug Experience Aims and scope Submit manuscript

Summary

Histamine H2-receptor antagonists are widely used in the treatment of gastrointestinal diseases related to gastric acid hypersecretion. Cimetidine was introduced into medical practice in 1976 and ranitidine, famotidine and nizatidine in 1981, 1985 and 1987, respectively. Haematological adverse effects are relatively uncommon and most have been reported in cases of cimetidine administration.

These adverse effects are reviewed under 4 main headings: (a) blood cytopenias and leucocytosis; (b) coagulation disorders related to drug interactions with oral anticoagulants; (c) reduction of dietary iron absorption; and (d) reduction of dietary cobalamin absorption.

85 reported cases of blood cytopenias attributed to these drugs are reviewed, of which 75 (88%) were associated with cimetidine therapy. In postmarketing surveillance studies, the incidence of cimetidine-associated blood cytopenia has been evaluated at about 2.3 per 100,000 patients. Neutropenia and agranulocytosis are by far the most frequently encountered. Whatever the drug or the type of cytopenia, this adverse effect is almost always rapidly reversible when treatment is stopped. Moreover, in several cases other factors suchas underlying diseases or additional drugs could have been responsible, at least partly, for the cytopenia. The pathophysiological basis of these adverse effects remains poorly explained. Various mechanisms have been proposed, which in some cases are probably associated: (a) direct toxicity for haemopoietic stem cells; (b) drug-induced immune reactions leading to blood or bone marrow cell damage, and (c) drug interactions, with increased and prolonged action of potentially haematotoxic drugs. Mechanisms (a) and (c) appear to be of particular clinical importance in cases of impaired renal elimination of H2-receptor antagonists.

Cimetidine and probably to a lesser extent ranitidine potentiate the action of oral anticoagulants of both coumarin and indanedione structure. This may result in haemorrhagic complications. Such action is a consequence of the reduced hepatic metabolism of oral anticoagulants through a dose-dependent, reversible inhibition of cytochrome P450.

Malabsorption of dietary iron and cobalamin appears to result from inhibition of gastric secretions by the H2-receptor antagonists. This is of no clinical importance in short term treatment, but long term use of H2-receptor antagonists may theoretically contribute to the occurrence of iron or cobalamin deficiency anaemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abraham PA, Opsahl JA, Halstenson CE, Chremos AN, Matzke GR, et al. The effect of famotidine on renal function in patients with renal insufficiency. British Journal of Clinical Pharmacology 24: 385–389, 1987

    PubMed  CAS  Google Scholar 

  • Aglietta M, Stacchini A, Sanavio F, Piacibello W. H2-receptor antagonists and human granulopoiesis. Experientia 41: 375–376, 1985

    PubMed  CAS  Google Scholar 

  • Albin H, Couzigou P, Vincon G, Pehourcq F, Fleury B, et al. Pharmacocin/’etique de la cimetidine chez le cirrhotique ascitique. Gastroenterologie Clinique et Biologique 7: 251–255, 1983

    PubMed  CAS  Google Scholar 

  • Al-Kawas FH, Lenes BA, Sacher RA. Cimetidine and agranulocytosis. Annals of Internal Medicine 90: 992–993, 1979

    PubMed  CAS  Google Scholar 

  • Allen JI, Syropoulos HJ, Grant B, Eagon JC, Kay NE. Cimetidine modulates natural killer cell function of patients with chronic lymphocytic leukemia. Journal of Laboratory and Clinical Medicine 109: 396–401, 1987

    PubMed  CAS  Google Scholar 

  • Amos RJ, Kirk B, Amess JAL, Jones AL, Hinds CJ. Bone marrow hypoplasia during intensive care: bone marrow culture studies implicating ranitidine in the suppression of haemopoiesis. Human Toxicology 6: 503–506, 1987

    PubMed  CAS  Google Scholar 

  • Aymard JP, Balaud A, Netter P, Witz F, Colomb JN, et al. Hypoplasie médullaire avec pancytopénie sanguine associée à la prisé de cimetidine. Thérapie 36: 202–203, 1981

    PubMed  CAS  Google Scholar 

  • Aymard JP, Herbeuval M, Herbeuval R, Witz, F, Lederlin P, et al. Action de la cimetidine sur les cellules souches de la granulopoièse humaine (CFU-C): étude in vitro sur 31 patients. Pathologie et Biologie 30: 855–857, 1982

    PubMed  CAS  Google Scholar 

  • Bacigalupo A, Van Lint MT, Peralvo J, Piaggio G, Figari O, et al. Ranitidine and hematologic recovery in aplastic anemia. Haematologica (Pavia) 72: 378–379, 1987

    CAS  Google Scholar 

  • Bagby GC, Lawrence HJ, Neerhout RC. T-Lymphocyte-mediated granulopoietic failure: in vitro identification of prednisone-responsive patients. New England Journal of Medicine 309: 1073–1078, 1983

    PubMed  Google Scholar 

  • Belaiche J, Zittoun J, Marquet J, Nurit Y, Yvart J. Effet de la ranitidine sur la sécrétion de facteur intrinsèque gastrique et sur l’absorption de la vitamine B12. Gastroenterologie Clinique et Biologique 7: 381–384, 1983

    PubMed  CAS  Google Scholar 

  • Bell WR, Anderson KC, Noe DA, Silver BA. Reduction in the plasma clearance rate of warfarin induced by cimetidine. Archives of Internal Medicine 146: 2325–2328, 1986

    PubMed  CAS  Google Scholar 

  • Bianchi Porro G. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience. Digestion 32 (Suppl.l): 62–69, 1985

    PubMed  Google Scholar 

  • Binder HJ, Donaldson RM. Effect of cimetidine on intrinsic factor and pepsin secretion in man. Gastroenterology 74: 371–375, 1978

    PubMed  CAS  Google Scholar 

  • Black JW, Duncan WAM, Durant CJ, Ganellin CR, Parsons EM. Definition and antagonism of histamine H2-receptors. Nature 236: 385–390, 1972

    PubMed  CAS  Google Scholar 

  • Bodenheimer HC, Thayer WR. Hemochromatosis associated with chronic cimetidine therapy? Journal of Clinical Gastroenterology 3: 83–85, 1981

    PubMed  Google Scholar 

  • Brenner LO. Agranulocytosis and ranitidine. Annals of Internal Medicine 104: 896–897, 1986

    PubMed  CAS  Google Scholar 

  • Bretagne JF, Reymann JM, Tassou JJ, Alain H, Gosselin A, et al. Pharmacocinétique de la ranitidine par voie intraveineuse et son effet sur la sécrétion acide stimulée par la pentagastrine chez le cirrhotique. Gastroenterologie Clinique et Biologique 7: 355–361, 1983

    PubMed  CAS  Google Scholar 

  • Burland WL, Mills JG, Sharpe PC, Horton MA, Mollin DL. The effect of cimetidine on intrinsic factor secretion. In Burland WL & Simkins M (Eds) Cimetidine: Proceedings of the 2nd International Symposium on Histamine H2-Receptor Antagonists, pp. 177–183, Excerpta Medica, Amsterdam. 1977

    Google Scholar 

  • Burland WL, Sharpe PC, Colin-Jones DG, Turnbull PRG, Bowskill P. Reversal of metiamide-induced agranulocytosis during treatment with cimetidine. Lancet 2: 1085, 1975

    PubMed  CAS  Google Scholar 

  • Byron JW. Bone-marrow toxicity of metiamide. Lancet 2: 1350, 1976

    PubMed  CAS  Google Scholar 

  • Byron JW. Mechanism for histamine H2-receptor induced cell-cycle changes in the bone marrow stem cell. Agents and Actions 7: 209–213, 1977

    PubMed  CAS  Google Scholar 

  • Byron JW. Pharmacodynamic basis for the interaction of cimetidine with the bone marrow stem cells (CFU-S). Experimental Hematology 8: 256–263, 1980

    PubMed  CAS  Google Scholar 

  • Caffee HH, Bingham HG. Leukopenia and silver sulfadiazine. Journal of Trauma 22: 586–587, 1982

    PubMed  CAS  Google Scholar 

  • Callaghan JT, Bergstrom RF, Rubin, A, Chernish S, Crabtree R, et al. A pharmacokinetic profile of nizatidine in man. Scandinavian Journal of Gastroenterology 22 (Suppl. 136): 9–17, 1987

    Google Scholar 

  • Calzado MC, Garcia-Castellano JM, Manzanares RM, Martinez F, Prieto B, et al. Effects of cimetidine on haematopoiesis in vitro. British Journal of Pharmacology 75: 301–303, 1982

    PubMed  CAS  Google Scholar 

  • Campoli-Richards DM, Clissold SP. Famotidine: pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs 32: 197–221, 1986

    PubMed  CAS  Google Scholar 

  • Carloss HW, Tavassoli M, McMillan R. Cimetidine-induced granulocytopenia. Annals of Internal Medicine 93: 57–58, 1980

    PubMed  CAS  Google Scholar 

  • Chandrasekhara KL, Iyer SK, Macchia RJ. Leucopenia and thrombocytopenia with cimetidine. Journal of the National Medical Association 73: 92–98, 1981

    PubMed  CAS  Google Scholar 

  • Chang HK, Morrison SL. Bone-marrow suppression associated with cimetidine. Annals of Internal Medicine 91: 580, 1979

    PubMed  CAS  Google Scholar 

  • Ching MS, Mihaly GW, Morgan DJ, Date NM, Hardy KJ, et al. Low clearance of cimetidine across the human placenta. Journal of Pharmacology and Experimental Therapeutics 241: 1006–1009, 1987

    PubMed  CAS  Google Scholar 

  • Choonara IA, Cholerton S, Haynes BP, Breckenridge AM, Park BK. Interaction between the R enantiomer of warfarin and cimetidine. British Journal of Clinical Pharmacology 21: 85P-86P, 1986

    Google Scholar 

  • Cloud ML, Safety of nizatidine in clinical trials conducted in the USA and Europe. Scandinavian Journal of Gastroenterology 22 (Suppl. 136): 29–36, 1987

    Google Scholar 

  • Colin-Jones DG, Langman MJS, Lawson DH, Vessey MP. Postmarketing surveillance of the safety of cimetidine: twelve-month morbidity report. Quarterly Journal of Medicine 54: 253–268, 1985

    PubMed  CAS  Google Scholar 

  • Collen MJ. Cimetidine-associated thrombocytopenia and leukopenia. Western Journal of Medicine 132: 257–258, 1980

    PubMed  CAS  Google Scholar 

  • Corbett CL, Holdsworth CD. Fever, abdominal pain, and leucopenia during treatment with cimetidine. British Medical Journal 1: 753–754, 1978

    PubMed  CAS  Google Scholar 

  • Crapper RM. Fatal agranulocytosis attributable to cimetidine. Medical Journal of Australia 2: 250–251, 1981

    PubMed  CAS  Google Scholar 

  • Craven ER, Whittington JM. Agranulocytosis four months after cimetidine therapy. Lancet 2: 294–295, 1977

    PubMed  CAS  Google Scholar 

  • Dammann HG, Dorner M, Greten H. Granulozytopenie bei Behandlung mit Cimetidin. Deutsche Medizinische Wochenschrift 106: 1276, 1981

    Google Scholar 

  • Danilewitz M, Ou Tim L, Hirschowilz B. Ranitidine suppression of gastric hypersecretion resistant to cimetidine. New England Journal of Medicine 306: 20–22, 1982

    PubMed  CAS  Google Scholar 

  • Davis TG, Pickett DL, Schlosser JH. Evaluation of a worldwide spontaneous reporting system with cimetidine. Journal of the American Medical Association 243: 1912–1914, 1980

    PubMed  CAS  Google Scholar 

  • De Galocsy C, Van Ypersele de Strihou C. Pancytopenia with cimetidine. Annals of Internal Medicine 90: 274, 1979

    PubMed  Google Scholar 

  • Denis J, Thierman-Duffaud D, Opolon P, Levy VG. Thrombopénie induite par la cimétidine. Nouvelle Presse Médicale 10: 2440, 1981

    PubMed  CAS  Google Scholar 

  • Desmond PV, Mashford ML, Harman PJ, Morphett BJ, Breen KJ, et al. Decreased oral warfarin clearance after ranitidine and cimetidine. Clinical Pharmacology and Therapeutics 35: 338–341, 1984

    PubMed  CAS  Google Scholar 

  • Devanesen S. Prolongation of prothrombin time with cimetidine. Medical Journal of Australia 1: 537, 1981

    PubMed  CAS  Google Scholar 

  • Dölle W, Sewing KF. Agranulocytosis after cimetidine after agranulocytosis induced by carbimazole in a woman with cirrhosis of the liver, hypersplenism and hyperthyroidism. Zeitschrift für Gastroenterologie 18: 81–82, 1980

    PubMed  Google Scholar 

  • Donn KH, Powell JR, Rogers JF, Plachetka JR. Lack of effect of histamine H2-receptor antagonists on indocyanine green disposition measured by two methods. Journal of Clinical Pharmacology 24: 360–370, 1984

    PubMed  CAS  Google Scholar 

  • Druart F, Frocrain C, Metois P, Martin J, Matuchansky C. Association of cimetidine and bone-marrow suppression in man. Digestive Diseases and Sciences 24: 730–731, 1979

    PubMed  CAS  Google Scholar 

  • Dubost JL, Chevallier H, Sultan R, Fallouh H. Neutropenie chez un malade traité par la cimétidine. Médecine et Chirurgie Digestive 9: 523–524, 1980

    CAS  Google Scholar 

  • Elizaga FV, Jim RTS, Lam CBC, Berman SJ. Hematologic effects of cimetidine. Annals of Internal Medicine 94: 280, 1981

    PubMed  CAS  Google Scholar 

  • Eridani S, Johnston IDA, Villa S. Cimetidine and granulopoiesis. Annals of Internal Medicine 97: 620, 1982

    PubMed  CAS  Google Scholar 

  • Esposito R. Cimetidine and iron-deficiency anaemia. Lancet 2: 1132, 1977

    PubMed  CAS  Google Scholar 

  • Farber BF, Brody JP. Rapid development of aplastic anemia after intravenous chloramphenicol and cimetidine therapy. Southern Medical Journal 74: 1257–1258, 1981

    PubMed  CAS  Google Scholar 

  • Feely J, Guy E. Ranitidine also reduces liver blood flow. Lancet 1: 169, 1982

    Google Scholar 

  • Feely J, Wilkinson GR, Wood AJJ. Reduction of liver blood flow and propranolol metabolism by cimetidine. New England Journal of Medicine 304: 692–695, 1981

    PubMed  CAS  Google Scholar 

  • Feldman EJ. Isenberg JL Effects of metiamide on gastric acid hypersecretion, steatorrhea and bone-marrow function in a patient with systemic mastocytosis. New England Journal of Medicine 295: 1178–1179, 1976

    PubMed  CAS  Google Scholar 

  • Fernandez-Rodriguez R, Moreno-Sanchez D, De Cuenca Moron B, Martinez-Fernandez R. Leucopenia reversible asociada al uso de cimetidina. Medica Clinica (Barcelona) 88: 123, 1987

    CAS  Google Scholar 

  • Fielding LP, Chalmers DM, Chanarin I, Levi AJ. Inhibition of intrinsic factor secretion by cimetidine. British Medical Journal 1: 818–819, 1978

    PubMed  CAS  Google Scholar 

  • Fischer J. Ranitidine and warfarin interaction. Drug Intelligence and Clinical Pharmacy 19: 664–665, 1985

    Google Scholar 

  • Fitchen JH, Koeffler HP. Cimetidine and granulopoiesis: bone marrow culture studies in normal man and patients with cimetidine-associated neutropenia. British Journal of Haematology 46: 361–366, 1980

    PubMed  CAS  Google Scholar 

  • Fleischer D, Samloff IM. Cimetidine therapy in a patient with metiamide-induced agranulocytosis. New England Journal of Medicine 296: 342, 1977

    PubMed  CAS  Google Scholar 

  • Flind AC. Cimetidine and oral anticoagulants. British Medical Journal 2: 1367, 1978

    PubMed  CAS  Google Scholar 

  • Forrest JAH, Shearman DJC, Spence R, Celestin LR. Neutropenia associated with metiamide. Lancet 1: 392–393, 1975

    PubMed  CAS  Google Scholar 

  • Gafter U, Komlos L, Weinstein T, Zevin D, Levi J. Thrombocytopenia, eosinophilia and ranitidine. Annals of Internal Medicine 106: 477, 1987

    PubMed  CAS  Google Scholar 

  • Gamelli RL, Foster RS, Whisnant JK. Hematopoietic toxicity of cimetidine: reexamination using the antimetabolite azathioprine. Transplantation 35: 12–14, 1983

    PubMed  CAS  Google Scholar 

  • Garg DC, Weidler DJ, Jallad NS, Eshelman FN. The effects of ranitidine and cimetidine on hepatic blood flow. Clinical Pharmacology and Therapeutics 31: 228, 1982

    Google Scholar 

  • Gelwan JS, Schmitz RL, Pellecchia C. Ranitidine and leukocytosis. American Journal of Gastroenterology 81: 685–687, 1986

    PubMed  CAS  Google Scholar 

  • Gibson PR, Pidcock ME. Immune-mediated thrombocytopenia associated with ranitidine therapy. Medical Journal of Australia 145: 661–662, 1986

    PubMed  CAS  Google Scholar 

  • Glotzbach RE. Cimetidine-induced thrombocytopenia. Southern Medical Journal 75: 232–234, 1982

    PubMed  CAS  Google Scholar 

  • Goldberg A, Lochhead AC, Dagg JH. Histamine-fast achlorhydria and iron absorption. Lancet 1: 848–850, 1963

    PubMed  CAS  Google Scholar 

  • Gouffier E, Schnurmann D, Durepaire H, Vernant JP. Aplasie médullaire transitoire au cours d’un traitement par la cimétidine. Nouvelle Presse Médicale 7: 2660, 1978

    PubMed  CAS  Google Scholar 

  • Grasela DM, Rocci ML, Rotmensch HH, Vlasses PH. Multiple dose cimetidine does not affect indocyanine green clearance. Drug Intelligence and Clinical Pharmacy 17: 454, 1983

    Google Scholar 

  • Grillot-Courvalin C, Vinci G, Tsapis A, Dokhelar MC, Vainchenker W, et al. The syndrome of T8 hyperlymphocytosis: variation in phenotype and cytotoxic activities of granular cells and evaluation of their role in associated neutropenia. Blood 69: 1204–1210, 1986

    Google Scholar 

  • Gross S, Worthington-White DA. Cimetidine suppression of CFU-C in males. American Journal of Hematology 17: 279–286, 1984

    PubMed  CAS  Google Scholar 

  • Hamborg B, Kittang E, Schjonsby H. The effect of ranitidine on the absorption of food cobalamins. Scandinavian Journal of Gastroenterology 20: 756–758, 1985

    PubMed  CAS  Google Scholar 

  • Harenberg J, Staiger C, De Vries JX, Walter E, Weber E, et al. Cimetidine does not increase the anticoagulant effect of phenprocoumon. British Journal of Clinical Pharmacology 14: 292–293, 1982

    PubMed  CAS  Google Scholar 

  • Harmon DC, Shuman R. Ranitidine. New England Journal of Medicine 310: 1604, 1984

    Google Scholar 

  • Hast R, Bernell P, Befrits R, Dowding C, Sjögren AM. Decrease in helper (T4+) lymphocytes following cimetidine treatment for duodenal ulcer. Clinical and Experimental Immunology 64: 114–118, 1986

    PubMed  CAS  Google Scholar 

  • Herrera A, Solal-Celigny P, Dresch C, Vallin J, Bernades P. Ranitidine. New England Journal of Medicine 310: 1604–1605, 1984

    Google Scholar 

  • Hess WA, Kornblith PL. Combination of lomustine and cimetidine in the treatment of a patient with malignant glioblastoma: a case report. Cancer Treatment Reports 69: 733, 1985

    PubMed  CAS  Google Scholar 

  • Hetzel D, Birkett D, Miners J. Cimetidine interaction with warfarin. Lancet 2: 639, 1979

    PubMed  CAS  Google Scholar 

  • Hetzel DJ, Bochner F, Hallpike JF, Shearman DJC, Hann CS. Cimetidine interaction with phenytoin. British Medical Journal 282: 1512, 1981

    PubMed  CAS  Google Scholar 

  • Hummer-Sigiel M, Girard A, Mandoria JY, Colson T, Jacquier A. Thrombopénie sous ranitidine et thiophenicol: responsabilité du thiophenicol. Cahiers d’Anesthésiologie 33: 363–365, 1985

    PubMed  CAS  Google Scholar 

  • Humphries TJ. Famotidine: a notable lack of drug interaction. Scandinavian Journal of Gastroenterology 22 (Suppl. 134): 55–60, 1987

    Google Scholar 

  • Idvall J. Cimetidine-associated thrombocytopenia. Lancet 2: 159, 1979

    PubMed  CAS  Google Scholar 

  • Imai Y, Inada M, Tamura S, Kawata S, Minami Y, et al. Comparative effects of famotidine and cimetidine on 7-ethoxycoumarin O-deethylase activity in human livers. British Journal of Clinical Pharmacology 22: 495–496, 1986

    PubMed  CAS  Google Scholar 

  • Isaacs AJ. Cimetidine and thrombocytopenia. British Medical Journal 280: 294, 1980

    PubMed  CAS  Google Scholar 

  • Iyer SK, Chandrasekhara KL. Leukopenia with cimetidine. Journal of the National Medical Association 72: 805–806, 1980

    PubMed  CAS  Google Scholar 

  • Jacobs A, Owen GM. Effect of gastric juice on iron absorption in patients with gastric atrophy. Gut 10: 488–490, 1969

    PubMed  CAS  Google Scholar 

  • Jacobs A, Rhodes J, Peters DK, Campbell H, Eakins JD. Gastric acidity and iron absorption. British Journal of Haematology 12: 728–736, 1966

    PubMed  CAS  Google Scholar 

  • James C, Prout BJ. Marrow suppression and intravenous cimetidine. Lancet 1: 987, 1978

    PubMed  CAS  Google Scholar 

  • Johnson NM, Black AE, Hughes ASB, Clarke SW. Leucopenia with cimetidine. Lancet 2: 1226–1227, 1977

    Google Scholar 

  • Jorizzo JL, Sams WM, Jegasothy BV, Olansky J. Cimetidine as an immunomodulator: chronic mucocutaneous candidiasis as a model. Annals of Internal Medicine 92: 192–195, 1980

    PubMed  CAS  Google Scholar 

  • Keller HJ, Kirste G, Wilms H. Cimetidin-induzierte Leukopenie nach Nierentransplantation. Deutsche Medizinische Wochenschrift 108: 1128–1129, 1983

    PubMed  CAS  Google Scholar 

  • Khokhar N, Akavaram NR. Cimetidine-induced leukopenia: case reports. Military Medicine 145: 853–855, 1980

    PubMed  CAS  Google Scholar 

  • Kirch W, Hoensch H, Janisch HD. Interactions and non-interactions with ranitidine. Clinical Pharmacokinetics 9: 493–510, 1984

    PubMed  CAS  Google Scholar 

  • Kitchens CS. Lack of antiplatelet effect of cimetidine in hemophiliacs. Southern Medical Journal 73: 391–392, 1980

    PubMed  CAS  Google Scholar 

  • Klotz SA, Kay BF. Cimetidine and agranulocytosis. Annals of Internal Medicine 88: 579–580, 1978

    PubMed  CAS  Google Scholar 

  • Klotz U. Lack of effect of nizatidine on drug metabolism. Scandinavian Journal of Gastroenterology 22 (Suppl. 136): 18–23,1987

    Google Scholar 

  • Knodell RG, Holtzman JL, Crankshaw DL, Steele NM, Stanley LN. Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists. Gastroenterology 82: 84–88, 1982

    PubMed  CAS  Google Scholar 

  • Lambie DG, Johnson RH. Drugs and folate metabolism. Drugs 30: 145–155, 1985

    PubMed  CAS  Google Scholar 

  • Lavarenne J, Maradeix B. Atteintes de la lignée blanche et cimetidine. Thérapie 37: 385–388, 1982

    PubMed  CAS  Google Scholar 

  • Lavarenne J, Moreau C. Les effets indésirables de la cimétidine: travail coopératif des centres de pharmacovigilance hospitalière, bilan des observations et confrontation aux données de la littérature. Thérapie 35: 83–112, 1980

    PubMed  CAS  Google Scholar 

  • Lebert PA, McLeod SM, Mahon WA, Soldin SJ, Vandenberghe HM. Ranitidine kinetics and dynamics, I: oral dose studies. Clinical Pharmacology and Therapeutics 30: 539–544, 1981

    PubMed  CAS  Google Scholar 

  • Lederlin P, Witz F, Colomb JN, Rumilly F, Eisenmann JC, et al. Aspects cliniques, étiologiques et évolutifs des agranulocytoses aigues médicamenteuses: à propos de 42 observations. Thérapie 37: 389–393, 1982

    PubMed  CAS  Google Scholar 

  • Legendre C, Canaud B, Beraud JJ, Brunin JL, Balmes JL, et al. Neutropenie sévère, récidivante et reversible induite par la cimétidine. Presse Médicale 13: 44, 1984

    CAS  Google Scholar 

  • Lewis DS, Beck ER. Reversible agranulocytosis in association with cimetidine and hepatic failure. Postgraduate Medical Journal 58: 443–444, 1982

    PubMed  CAS  Google Scholar 

  • Lin JH, Cocchetto DM, Yeh KC, Dugan DE. Comparative effects of H2-receptor antagonists on drug interaction in rats. Drug Metabolism and Disposition 14: 649–653, 1986

    PubMed  CAS  Google Scholar 

  • Linhardt GE, Gadacz TR. Prolonged WBC depression after cimetidine in a patient with chronic myelogenous leukemia. Southern Medical Journal 74: 353–355, 1981

    PubMed  Google Scholar 

  • List AF, Beaird DH, Kummet T. Ranitidine-induced granulocytopenia: recurrence with cimetidine administration. Annals of Internal Medicine 108: 566–567, 1988

    PubMed  CAS  Google Scholar 

  • Littlejohn GO, Urowitz MB. Cimetidine, lupus erythematosus, and granulocytopenia. Annals of Internal Medicine 91: 317–318, 1979

    PubMed  CAS  Google Scholar 

  • Lopez-Luque A, Rodriguez-Cuartero A, Perez-Galvez N, Pomares-Mora J, Pena-Yanez A. Cimetidine and bone-marrow toxicity. Lancet 1: 444, 1978

    PubMed  CAS  Google Scholar 

  • Ma KW, Brown DC, Masler DS, Silvis SE. Effects of renal failure on blood levels of cimetidine. Gastroenterology 74: 473–477, 1978

    PubMed  CAS  Google Scholar 

  • Mann HJ, Schneider JR, Miller JB, Delaney JP. Cimetidine-associated thrombocytopenia. Drug Intelligence and Clinical Pharmacy 17: 126–128, 1983

    PubMed  CAS  Google Scholar 

  • Mar DD, Brandstetter RD, Miskovitz PF, Fotino M. Cimetidine-induced, immune-mediated leukopenia and thrombocytopenia. Southern Medical Journal 75: 1283–1285, 1982

    PubMed  CAS  Google Scholar 

  • Mashford ML, Harman PJ, Morphett BJ, Breen KJ, Desmond PV. Ranitidine does not affect chlormethiazole or indocyanine green disposition. Clinical Pharmacology and Therapeutics 34: 231–233, 1983

    PubMed  CAS  Google Scholar 

  • McDaniel JL, Stein JJ. Thrombocytopenia with cimetidine therapy. New England Journal of Medicine 300: 864, 1979

    PubMed  CAS  Google Scholar 

  • McGowan WAW. Safety of cimetidine in obstetric patients. Journal of the Royal Society of Medicine 72: 902–907, 1979

    PubMed  CAS  Google Scholar 

  • McGregor CGA, Cochran AJ, Ogg LJ, Gray GR, Smith IS, et al. Immunological and other laboratory studies of patients receiving short-term cimetidine therapy. Lancet 1: 122–123, 1977

    PubMed  CAS  Google Scholar 

  • Mikhailidis DP, Mikhailidis AM, Dandona P. Prevention or cure for stress-induced gastrointestinal bleeding. British Medical Journal 281: 1005–1006, 1980

    PubMed  CAS  Google Scholar 

  • Mohammed R, Clark JS, Adams JF, Hearns JB, Crean GP. The effect of ranitidine hydrochloride, a new histamine H2-receptor antagonist, on intrinsic factor secretion. Clinical Therapeutics 4: 118–120, 1981

    PubMed  CAS  Google Scholar 

  • Morichau-Beauchant M, Houin, G, Mavier P, Alexandre C, Dhumeaux D. Pharmacokinetics and bioavailability of ranitidine in normal subjects and cirrhotic patients. Digestive Diseases and Sciences 31: 113–118, 1986

    PubMed  CAS  Google Scholar 

  • Mountford R, Preece AW, Jones R, Grove E, Cottrell J. Effect of treatment with famotidine on T-lymphocyte populations and activity in duodenal ulcer patients. Gut 28: A1338–A1339, 1987

    Google Scholar 

  • Nagler A, Rozenbaum H, Enat R, Tatarsky I, Katz R, et al. Immune basis for cimetidine-induced pancytopenia. American Journal of Gastroenterology 82: 359–361, 1987

    PubMed  CAS  Google Scholar 

  • Nakatani T. Granulocytopenia associated with ranitidine in a patient with renal transplant. British Medical Journal 295: 333, 1987

    Google Scholar 

  • Nouel O, Pariente EA, Slaoui H, Renoux M. Agranulocytose à la cimétidine: un accident immuno-allergique? Gastroenterologie Clinique et Biologique 3: 481, 1979

    PubMed  CAS  Google Scholar 

  • Ohnishi K, Saito M, Nomura F, Okuda K, Suzuki N, et al. Effect of famotidine on hepatic hemodynamics and peptic ulcer. American Journal of Gastroenterology 82: 415–418, 1987

    PubMed  CAS  Google Scholar 

  • O’Reilly RA. Comparative interaction of cimetidine and ranitidine with racemic warfarin in man. Archives of Internal Medicine 144: 989–991, 1984

    PubMed  Google Scholar 

  • Patwardhan RV, Yarborough GW, Desmond PV, Johnson RF, Schenker S, et al. Cimetidine spares the glucuronidation of lorazepam and oxazepam. Gastroenterology 79: 912–916, 1980

    PubMed  CAS  Google Scholar 

  • Peden NR, Boyds EJS, Brown RA, Gibbs JH, Potts RC, et al. Cimetidine, the immune system, and cancer. Lancet 1: 900–901, 1981

    Google Scholar 

  • Peden NR, Robertson AJ, Boyd EJS, Brown RA, Gibbs JH, et al. Mitogen stimulation of peripheral blood lymphocytes of duodenal ulcer patients during treatment with cimetidine or ranitidine. Gut 23: 398–403, 1982

    PubMed  CAS  Google Scholar 

  • Petz LD, Gitlin N, Grant K, Rodvien R, Brotman M. Cimetidine-induced hemolytic anemia: the fallacy of clinical associations. Journal of Clinical Gastroenterology 5: 405–409, 1983

    PubMed  CAS  Google Scholar 

  • Posnett DN, Stein RS, Graber SE, Krantz SB. Cimetidine-induced neutropenia: a possible dose-related phenomenon. Archives of Internal Medicine 139: 584–586, 1979

    PubMed  CAS  Google Scholar 

  • Powell JR, Donn KH. Histamine H2-antagonist drug interactions in perspective: mechanistic concepts and clinical implications. American Journal of Medicine 77 (Suppl. 5B): 57–84, 1984

    PubMed  CAS  Google Scholar 

  • Puurunen J, Sotaniemi E, Pelkonen O. Effect of cimetidine on microsomal drug metabolism in man. European Journal of Clinical Pharmacology 18: 185–187, 1980

    PubMed  CAS  Google Scholar 

  • Rate R, Bonnell M, Chervenak C, Pavinich G. Cimetidine and hematologic effects. Annals of Internal Medicine 91: 795, 1979

    PubMed  CAS  Google Scholar 

  • Reddy J, Bailey RR. Cimetidine and thrombocytopenia. New Zealand Medical Journal 91: 232, 1980

    PubMed  CAS  Google Scholar 

  • Reiffers J, Piquet Y, Roussy P, Boisseau C, Couzigou P, et al. Thrombopenie après traitement par cimétidine. Nouvelle Presse Médicale 10: 2586–2587, 1981

    PubMed  CAS  Google Scholar 

  • Reilly PEB, Carrington LE, Winzor DJ. The interaction of cimetidine with rat liver microsomes. Biochemical Pharmacology 32: 831–835, 1983

    PubMed  CAS  Google Scholar 

  • Rendic S, Alebic-Kolbah T, Kajfez F, Ruf HH. Interaction of ranitidine with liver microsomes. Xenobiotica 12: 9–17, 1982

    PubMed  CAS  Google Scholar 

  • Rendic S, Kajfez F, Ruf HH. Characterization of cimetidine, ranitidine and related structures’ interaction with cytochrome P-450. Drug Metabolism and Disposition 11: 137–142, 1983

    PubMed  CAS  Google Scholar 

  • Rendic S, Sunjic V, Toso R, Kajfez F, Ruf HH. Interaction of cimetidine with liver microsomes. Xenobiotica 9: 555–564, 1979

    PubMed  CAS  Google Scholar 

  • Richter JE, Gerhardt DC, Pasquale DN, Castell DO. Cimetidine and hematologic suppression: things are not always as they appear. Digestive Diseases and Sciences 25: 960–963, 1980

    PubMed  CAS  Google Scholar 

  • Rotoli B, Formisano S, Alfinito F. Autoimmune haemolytic anaemia associated with cimetidine. Lancet 2: 583, 1979

    PubMed  CAS  Google Scholar 

  • Rowley-Jones D, Flind AC. Continuing evaluation of the safety of cimetidine. In Baron (Ed.) Cimetidine in the 80s, pp. 261–269, Churchill Livingstone, Edinburgh, 1981

    Google Scholar 

  • Sahasrabudhe DM, McCune CS, O’Donnell RW, Henshaw EC. Inhibition of suppressor T lymphocytes (Ts) by cimetidine. Journal of Immunology 138: 2760–2763, 1987

    CAS  Google Scholar 

  • Saigenji K, Fukutomi H, Nakazawa S. Famotidine: postmarketing clinical experience. Scandinavian Journal of Gastroenterology 22 (Suppl. 134): 34–40, 1987

    Google Scholar 

  • Salom IL, Silvis SE, Doscherholmen A. Effect of cimetidine on the absorption of vitamin B12. Scandinavian Journal of Gastroenterology 17: 129–131, 1982

    PubMed  CAS  Google Scholar 

  • Sasaki Y, Hayashi N, Kasahara A, Matsuda Y, Furusawa S, et al. Influence of ranitidine on hepatic blood flow assessed by organ-reflectance spectrophotometer and pulse-doppler ultrasonic flowmeter. Digestive Diseases and Sciences 30: 1043–1048, 1985

    PubMed  CAS  Google Scholar 

  • Sazie E, Jaffe JP. Severe granulocytopenia with cimetidine and phenytoin. Annals of Internal Medicine 93: 151–152, 1980

    PubMed  CAS  Google Scholar 

  • Schentag JJ, Cerra FB, Calleri GM, Leising ME, French MA, et al. Age, disease, and cimetidine disposition in healthy subjects and chronically ill patients. Clinical Pharmacology and Therapeutics 29: 737–743, 1981

    PubMed  CAS  Google Scholar 

  • Schmitt J, Jacquier A, Huttin B, Lambert H, Baille N, et al. Pancytopenie aigue avec atteinte médullaire au cours d’un traitement par la cimétidine. Nouvelle Presse Médicale 8: 2982, 1979

    PubMed  CAS  Google Scholar 

  • Sedman AJ. Cimetidine-drug interactions. American Journal of Medicine 76: 109–114, 1984

    PubMed  CAS  Google Scholar 

  • Selker HP, Rosenbloom BE, Weinstein IM. Cimetidine and cytopenia. Western Journal of Medicine 135: 330–336, 1981

    PubMed  CAS  Google Scholar 

  • Serlin MJ, Sibeon RG, Breckenridge AM. Lack of effect of ranitidine on warfarin action. British Journal of Clinical Pharmacology 12: 791–794, 1981

    PubMed  CAS  Google Scholar 

  • Serlin MJ, Sibeon RG, Mossman S, Breckenridge AM, Williams JRB, et al. Cimetidine: interaction with oral anticoagulants in man. Lancet 2: 317–319, 1979

    PubMed  CAS  Google Scholar 

  • Shields LI, Files JA, Doll DC, Greenberg BR. Ranitidine and agranulocytosis. Annals of Internal Medicine 104: 128, 1986

    PubMed  CAS  Google Scholar 

  • Sica DA, Comstock T, Harford A, Eshelman F. Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis. European Journal of Clinical Pharmacology 32: 587–591, 1987

    PubMed  CAS  Google Scholar 

  • Silver BA, Bell WR, Cimetidine potentiation of the hypoprothrombinemic effect of warfarin. Annals of Internal Medicine 90: 348–349, 1979

    PubMed  CAS  Google Scholar 

  • Sinco A, Conte G, Ambriz R, Aviles A, Morales MR, et al. Cimetidina y neutropenia transitoria en un paciente con hemophilia. Revista de Investigacion Clinica (Mexico) 33: 289–291, 1981

    CAS  Google Scholar 

  • Skikne BS, Lynch SR, Cook JD. Role of gastric acid in iron food absorption. Gastroenterology 81: 1068–1071, 1981

    PubMed  CAS  Google Scholar 

  • Smith SR, Kendall MJ. Ranitidine versus cimetidine: a comparison of their potential to cause clinically important drug interactions. Clinical Pharmacokinetics 15: 44–56, 1988

    PubMed  CAS  Google Scholar 

  • Smout AJPM, Bakker B. Agranulocytose door cimetidine. Nederlands Tijdschrift voor Geneeskunde (Amsterdam) 125: 2152–2154, 1981

    CAS  Google Scholar 

  • Somogyi A, Gugler R. Cimetidine excretion into breast milk. British Journal of Clinical Pharmacology 7: 627–629, 1979

    PubMed  CAS  Google Scholar 

  • Somogyi A, Gugler R. Drug interactions with cimetidine. Clinical Pharmacokinetics 7: 23–41, 1982

    PubMed  CAS  Google Scholar 

  • Somogyi A, Muirhead M. Pharmacokinetic interactions of cimetidine 1987. Clinical Pharmacokinetics 12: 321–366, 1987

    PubMed  CAS  Google Scholar 

  • Sonne J, Poulsen HE, Dossing M, Larsen NE, Andreasen PB. Cimetidine clearance and bioavailability in hepatic cirrhosis. Clinical Pharmacology and Therapeutics 29: 191–197, 1981

    PubMed  CAS  Google Scholar 

  • Sorkin EM, Darvey DL. Review of cimetidine drug interactions. Drug Intelligence and Clinical Pharmacy 17: 110–120, 1983

    PubMed  CAS  Google Scholar 

  • Speeg KV, Patwardhan RV, Avant GR, Mitchell MC, Schenker S. Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents. Gastroenterology 82: 89–96, 1982

    PubMed  CAS  Google Scholar 

  • Spinka R, Honetz N. Akute granulozytopenie unter cimetidin. Wiener Medizinische Wochenschrift 134: 141–145, 1984

    PubMed  CAS  Google Scholar 

  • Spychal RT, Wickham NWR. Thrombocytopenia associated with ranitidine. British Medical Journal 291: 1687, 1985

    PubMed  CAS  Google Scholar 

  • Stein RS, Howard CA. Clinical assessment of cimetidine myelotoxicity. Southern Medical Journal 73: 293–294, 1981

    Google Scholar 

  • Steinberg WM, King CE, Toskes PP. Malabsorption of protein-bound cobalamin but not unbound cobalamin during cimetidine administration. Digestive Diseases and Sciences 25: 188–192, 1980

    PubMed  CAS  Google Scholar 

  • Streeter AM, Duraiappah B, Boyle R, O’Neill BJ, Pheils MT. Malabsorption of vitamin B12 after vagotomy. American Journal of Surgery 128: 340–343, 1974

    PubMed  CAS  Google Scholar 

  • Streeter AM, Goulston KJ, Bathur FA, Hilmer RS, Crane GG, et al. Cimetidine and malabsorption of cobalamin. Digestive Diseases and Sciences 27: 13–16, 1982

    PubMed  CAS  Google Scholar 

  • Takabatake T, Ohta H, Maekawa M, Yamamoto Y, Ishida Y, et al. Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function. European Journal of Clinical Pharmacology 28: 327–331, 1985

    PubMed  CAS  Google Scholar 

  • Tan-Ngamtrong D, Hitanant S, Vanasin B. Auto-immune hemolytic anemia during treatment with cimetidine. Journal of the Medical Association of Thailand 70: 156–159, 1987

    PubMed  CAS  Google Scholar 

  • Teichmann RK, Zumtobel V, Heberer G. Agranulozytose durch cimetidin. Chirurg 49: 397–398, 1978

    PubMed  CAS  Google Scholar 

  • Testa R, Grasso A, Dagnino F, Ibba R, Varagona G, et al. Famotidine does not affect indocyanine green disposition and serum bile acid levels in healthy subjects. British Journal of Clinical Pharmacology 23: 779–780, 1987

    PubMed  CAS  Google Scholar 

  • Texereau P, Ancelin P, Briaud M, Moussie D. Un cas d’agranulocytose aigue chez un malade traité par ranitidine. Gastroenterologie Clinique et Biologique 11: 829–830, 1987

    PubMed  CAS  Google Scholar 

  • Thijssen HHW, Janssen GMJ, Baars LGM. Lack of effect of cimetidine on pharmacodynamics and kinetics of single oral doses of R- and S-acenocoumarol. European Journal of Clinical Pharmacology 30: 619–623, 1986

    PubMed  CAS  Google Scholar 

  • Tishler M, Abramov AL. Cimetidine-induced eosinophilia. Drug Intelligence and Clinical Pharmacy 19: 377–378, 1985

    PubMed  CAS  Google Scholar 

  • Tomioka K, Yamada T, Tachikawa S. Effects of famotidine (YM-11170), an H2-receptor antagonist on in vivo immediate and delayed type hypersensitivity reactions and antibody formation. Drugs under Experimental and Clinical Research 9: 881–889, 1983

    CAS  Google Scholar 

  • Tong GL, Lien EJ. Biotransformation of drugs: quantitative structure-activity relationships for barbiturates, tertiary amines and substituted imidazoles. Journal of Pharmaceutical Science 65: 1651–1654, 1976

    CAS  Google Scholar 

  • Tonkonow B, Hoffman R. Aplastic anemia and cimetidine. Archives of Internal Medicine 140: 1123–1124, 1980

    PubMed  CAS  Google Scholar 

  • Toon S, Hopkins KJ. Garstang FM, Rowland M. Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man. European Journal of Clinical Pharmacology 32: 165–172, 1987

    PubMed  CAS  Google Scholar 

  • Truong TK, Grand’Maison F, Longpré B. Myelotoxicose due à la cimétidine. Union Médicale du Canada 115: 834–836, 1986

    PubMed  CAS  Google Scholar 

  • Tyden G, Thulin L, Nyberg B. The effect of cimetidine on liver blood flow in anaesthetized man. Acta Chirurgica Scandinavica 149: 303–305, 1983

    PubMed  CAS  Google Scholar 

  • Ufberg MH, Brooks CM, Bosanac PR, Kintzel JE. Transient neutropenia in a patient receiving cimetidine. Gastroenterology 73: 635–638, 1977

    PubMed  CAS  Google Scholar 

  • Valente P, Axelrod JL. Acute leukopenia associated with silver sulfadiazine therapy. Journal of Trauma 18: 146–147, 1978

    PubMed  CAS  Google Scholar 

  • Verma DS, Johnston DA, McCredie KB. Identification of T lymphocyte subpopulations that regulate elaboration of granulocyte-macrophage colony stimulating factor. British Journal of Haematology 57: 505–520, 1984

    PubMed  CAS  Google Scholar 

  • Vickers MR, Milliner KJ, Fallowfield C, Dracott BN. The effects of histamine H2-receptor antagonists on PHA induced lymphocyte proliferation. Agents and Actions 15: 242–248, 1984

    CAS  Google Scholar 

  • Villeneuve JP, Fortunet-Fouin H, Arsène D. Cimetidine kinetics and dynamics in patients with severe liver disease. Hepatology 3: 923–927, 1983

    PubMed  CAS  Google Scholar 

  • Volkin RL, Shadduck RK, Winkelstein A, Zeigler ZR, Selker R. Alternative mechanisms for severe neutropenia. Archives of Internal Medicine 142: 1971, 1982

    Google Scholar 

  • Wallin BA, Jacknowitz A, Raich PC. Cimetidine and effect of warfarin. Annals of Internal Medicine 90: 993, 1979

    PubMed  CAS  Google Scholar 

  • Wehr M, Schäfer K, Bode JC. Granulozytopenie unter Cimetidintherapie. Deutsche Medizinische Wochenschrift 105: 1571–1573, 1980

    PubMed  CAS  Google Scholar 

  • Wilkinson CF, Hetnarski K, Cantwell GP, Di Carlo FJ. Structure-activity relationships in the effects of 1-alkylimidazoles on microsomal oxidation in vitro and in vivo. Biochemical Pharmacology 23: 2377–2386, 1974

    PubMed  CAS  Google Scholar 

  • Wong YY, Lichtor T, Brown FD. Severe thrombocytopenia associated with phenytoin and cimetidine therapy. Surgical Neurology 23: 169–172, 1985

    PubMed  CAS  Google Scholar 

  • Yao E, Tsukasaki K, Kamei T, Kuriyama K, Ichimaru M. Effect of bolus methylprednisolone therapy on a case of cimetidine-associated aplastic anemia (in Japanese). Rinsho Ketsueki 28: 100–105, 1987

    PubMed  CAS  Google Scholar 

  • Yates VM, Kerr REI. Cimetidine and thrombocytopenia. British Medical Journal 280: 1453, 1980

    PubMed  CAS  Google Scholar 

  • Yeomans ND, Hanson RG, Smallwood RA, Mihaly GW, Louis WJ. Effect of chronic ranitidine treatment on secretion of intrinsic factor. British Medical Journal 285: 264, 1982

    PubMed  CAS  Google Scholar 

  • Yue CP, Mann KS, Chan KH. Severe thrombocytopenia due to combined cimetidine and phenytoin therapy. Neurosurgery 20: 963–965, 1987

    PubMed  CAS  Google Scholar 

  • Zeldis JB, Friedman LS, Isselbacher KJ. Ranitidine: a new H2-receptor antagonist. New England Journal of Medicine 309: 1368–1373, 1983

    PubMed  CAS  Google Scholar 

  • Zoumbos NC, Gascon P, Djeu JY, Trost SR, Young NS. Circulating activated suppressor T lymphocytes in aplastic anemia. New England Journal of Medicine 312: 257–265, 1985

    PubMed  CAS  Google Scholar 

  • Zulli P, Di Nisio Q. Cimetidine treatment during pregnancy. Lancet 2: 945–946, 1978

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Regional Blood Transfusion and Haematology Centre, Departments of Pathology and Clinical Pharmacology, University Hospital, Avenue de Bourgogne, 54500, Vandoeuvre-les-Nancy, France

    Jean-Pierre Aymard, Bernadette Aymard, Patrick Netter, Bernard Bannwarth, Philippe Trechot & François Streiff

Authors
  1. Jean-Pierre Aymard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bernadette Aymard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrick Netter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bernard Bannwarth
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Philippe Trechot
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. François Streiff
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aymard, JP., Aymard, B., Netter, P. et al. Haematological Adverse Effects of Histamine H2-Receptor Antagonists. Med Toxicol Adverse Drug Exp 3, 430–448 (1988). https://doi.org/10.1007/BF03259895

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259895

Keywords

Search

Navigation